| 06/23 | FluoroPharma Medical, Inc. Announces Executive Changes | CI |
| 06/23 | FluoroPharma Medical, Inc. Appoints Frank I Igwealor as CFO | CI |
| 2018 | FluoroPharma Medical, Inc. Restructures CardioPET License With Massachusetts General Ho.. | CI |
| 2017 | FluoroPharma Medical, Inc. cancelled the acquisition of Ground Fluor Pharmaceuticals, I.. | CI |
| 2017 | FluoroPharma Medical, Inc. Auditor Raises 'Going Concern' Doubt | CI |
| 2017 | FluoroPharma Medical, Inc. Announces Resignation of Lawrence Atinsky as Director and Me.. | CI |
| 2016 | FluoroPharma Medical, Inc. Borrows $50,000 in the Form of Promissory Note; Announces Bo.. | CI |
| 2016 | FluoroPharma Medical, Inc. announced that it has received $0.57 million in funding | CI |
| 2016 | FLUOROPHARMA MEDICAL, INC. (OTCPK : FPMI) entered into a nonbinding letter of intent to ac.. | CI |
| 2016 | FluoroPharma Medical, Inc. Enters into Development and Commercialization Agreement with.. | CI |
| 2016 | Fluoropharma Medical Inc. Accepts First Comparative Data from it's Phase II Trial of Ca.. | CI |
| 2016 | FluoroPharma Medical, Inc. Auditor Raises 'Going Concern' Doubt | CI |
| 2016 | FluoroPharma Medical, Inc. Announces Resignation of Andrew H. Sassine as Member of the .. | CI |
| 2015 | FluoroPharma Medical, Inc. Announces Management Appointments | CI |
| 2015 | FluoroPharma Medical, Inc. Announces Board Changes | CI |
| 2015 | FluoroPharma Medical Inc Appoints Dr. Thomas H. Tulip as President | CI |
| 2015 | FluoroPharma Medical, Inc. announced that it has received $2.78 million in funding | CI |
| 2015 | FluoroPharma Medical, Inc. announced that it has received $0.195 million in funding. | CI |
| 2015 | FluoroPharma Medical, Inc. Auditor Raises 'Going Concern' Doubt | CI |
| 2014 | FluoroPharma Medical, Inc. Announces the Data from its Phase II Clinical Trial of 18-F .. | CI |
| 2014 | FluoroPharma Medical, Inc. and The General Hospital Corporation Entered into Two Licens.. | CI |
| 2014 | Fluoropharma Medical, Inc. Presents Data from Phase II Clinical Trial of 18F FCPHA | CI |
| 2014 | FluoroPharma Medical, Inc. Appoints H. William Strauss to Chair the Scientific Advisory.. | CI |
| 2014 | FluoroPharma Medical, Inc. Auditor Raises 'Going Concern' Doubt | CI |
| 2014 | FluoroPharma Medical, Inc. Appoints Andrew H. Sassine to its Board of Directors, Effect.. | CI |
| 2014 | FluoroPharma Presents Data from Phase II Clinical Trial for (18) F-FCPHA | CI |
| 2013 | FluoroPharma Medical, Inc. Names Edward L. Lyons, Jr. to Newly Created Position of Vice.. | CI |
| 2013 | FluoroPharma Medical, Inc. announced that it expects to receive $0.50 million in fundin.. | CI |
| 2013 | FluoroPharma Medical, Inc. Announces Internal Review of Imaging Data From Phase II Stud.. | CI |
| 2013 | FluoroPharma Medical, Inc. Appoints Joseph A. Pierro as Board of Director | CI |
| 2013 | FluoroPharma Medical, Inc. Auditor Raises 'Going Concern' Doubt | CI |
| 2013 | FluoroPharma Medical, Inc. Releases Initial Data from Phase II Study for CardioPET | CI |
| 2013 | FluoroPharma Medical, Inc. Announces Phase II Study for BFPET (18)F-TPP | CI |
| 2012 | FluoroPharma Medical, Inc. announced that it has received $1.54625 million in funding | CI |
| 2012 | FluoroPharma Medical, Inc. Promotes Tamara Rhein to Chief Financial Officer | CI |
| 2012 | FluoroPharma Medical, Inc. Announces Milestone for BFPET | CI |
| 2012 | FluoroPharma Medical, Inc. Announces Executive Changes | CI |
| 2012 | FluoroPharma Medical, Inc. Decides to Eliminate Dr. Elmaleh's Status as an Executive Of.. | CI |
| 2012 | FluoroPharma Medical, Inc. Grants Patent Rights for BFPET in Australia | CI |
| 2012 | FluoroPharma Medical, Inc. Announces Phase II Study for CardioPET | CI |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
